StageZero’s James Howard-Tripp on diagnosing cancer early
“We are all about finding diseases early. Our current focus is on cancer. If you can find it early your survival is greatest, your costs are lower. That’s what it is all about.” States James Howard-Tripp, Chairman and CEO of StageZero Life Sciences, Ltd. (TSX: SZLS), in an interview with InvestorIntel’s Tracy Weslosky.
James went on to provide an update on StageZero’s collaboration with Coastal Medical (to increase outreach to physician practices and hospital systems throughout the Southeast). James said that they have fully trained the Salesforce and the Coastal Medical team is in the field. James also provided an update on StageZero’s recent private placement. He said that the private placement was fully subscribed and the company has raised $3.7 million. He further added that StageZero is expected to breakeven before year-end. The company is starting to ramp up and is expecting good growth in sales and revenue.
To access the complete interview, click here
Disclaimer: StageZero Life Sciences, Ltd. is an advertorial member of InvestorIntel Corp.